We are live on ! Find out more

Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
TAK icon
1
Takeda Pharmaceutical
TAK
$69.1B
$69.1B $21.62 0.14%
TEVA icon
2
Teva Pharmaceutical Industries
TEVA
$49.4B
$49.4B $42.31 0.61%
HLN icon
3
Haleon
HLN
$39.8B
$39.8B $9.07 1.41%
ZTS icon
4
Zoetis
ZTS
$33.8B
$33.8B $83.15 1.47%
UTHR icon
5
United Therapeutics
UTHR
$24.7B
$24.7B $580.86 1.19%
VTRS icon
6
Viatris
VTRS
$23.5B
$23.5B $20.50 1.16%
NBIX icon
7
Neurocrine Biosciences
NBIX
$16.7B
$16.7B $165.30 0.01%
ELAN icon
8
Elanco Animal Health
ELAN
$13B
$13B $25.98 1.63%
RDY icon
9
Dr. Reddy's Laboratories
RDY
$12.3B
$12.3B $14.80 0.68%
ALKS icon
10
Alkermes
ALKS
$7.64B
$7.64B $45.45 2.32%
KNSA icon
11
Kiniksa Pharmaceuticals
KNSA
$7.42B
$7.42B $94.42 0.2%
AMRX icon
12
Amneal Pharmaceuticals
AMRX
$7.29B
$7.29B $20.93 1.41%
LNTH icon
13
Lantheus
LNTH
$6.66B
$6.66B $101.78 0.06%
SUPN icon
14
Supernus
SUPN
$6.05B
$6.05B $29.11 0.97%
LQDA icon
15
Liquidia
LQDA
$5.04B
$5.04B $55.95 0.75%
HIMS icon
16
Hims & Hers Health
HIMS
$4.14B
$4.14B $17.64 4.96%
AMLX icon
17
Amylyx Pharmaceuticals
AMLX
$3.49B
$3.49B $27.17 2.27%
BHC icon
18
Bausch Health
BHC
$3.14B
$3.14B $8.38 0.48%
XERS icon
19
Xeris Biopharma Holdings
XERS
$3.06B
$3.06B $16.73 0.18%
HCM icon
20
HUTCHMED
HCM
$2.49B
$2.49B $14.35 2.58%
PBH icon
21
Prestige Consumer Healthcare
PBH
$2.29B
$2.29B $48.31 0.65%
RGC icon
22
Regencell Bioscience
RGC
$2.29B
$2.29B $4.61 2.33%
PRGO icon
23
Perrigo
PRGO
$2.2B
$2.2B $15.86 1.98%
BCRX icon
24
BioCryst Pharmaceuticals
BCRX
$1.92B
$1.92B $7.47 0.27%
ETON icon
25
Eton Pharmaceutcials
ETON
$1.81B
$1.81B $62.87 1.58%

Drug Manufacturers - Specialty & Generic Stocks at a Glance

Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.

There are 79 Drug Manufacturers - Specialty & Generic industry stocks tracked by Wall St. Rank, worth a combined $368B.

The largest by market cap are Takeda Pharmaceutical (TAK) at $69.1B, Teva Pharmaceutical Industries (TEVA) at $49.4B and Haleon (HLN) at $39.8B.

Among institutional investors, Eton Pharmaceutcials (ETON) drew the most net new fund positions in Q3 2026: 76 funds opened new positions, taking total fund holders up 49 (30%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q3 2026.